Uric Acid

Uric Acid

SCHEMBL925499

N.O=c1[nH]c(=O)c2[nH]c(=O)[nH]c2[nH]1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GDA Q9Y2T3 2/20 0.94
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
HPGD P15428 2/20 0.46
CYP2C19 P33261 2/20 0.46
HSD17B10 Q99714 2/20 0.46
ALOX15 P16050 1/20 0.46
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
BRPF1 P55201 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TYMP P19971 5/20 0.39
GSK3B P49841 1/20 0.39
BACE1 P56817 1/20 0.39
IDH1 O75874 1/20 0.39
CSNK2A2 P19784 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uric Acid SCHEMBL30062557 0.97 GDA (1.00) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL22069923 0.97 GDA (1.00) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL3417988 0.97 GDA (1.00) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL31391241 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL28360883 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL28375152 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL2437810 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL4325846 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL29767920 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD
Uric Acid SCHEMBL31462948 0.94 GDA (0.94) GDAALDH1A1CYP1A2CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12558363-B2 Compositions for clinical complications associated to devices implanted in the urinary tract Devicare SL (ES) 2026-02-24 US claimed
WO-2025075824-A1 URINE SEDIMENT INTERFACE WITH PROBABILISTIC CLASSIFICATION BINNING AND METHODS OF PRODUCING AND USING SAME SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2025-04-10 WO claimed
CN-119350093-A Preparation method of slow-release urea and application of slow-release urea in saline-alkali soil remediation 西北师范大学 2025-01-24 CN claimed
EP-4084836-B1 COMPOSITIONS FOR CLINICAL COMPLICATIONS ASSOCIATED TO DEVICES IMPLANTED IN THE URINARY TRACT DEVICARE S L (ES) 2024-10-09 EP claimed
CN-115038471-B Compositions for clinical complications associated with devices implanted in the urinary tract 德维护理有限公司 2024-05-14 CN claimed
CN-117317251-A Carbon-supported noble metal nano catalyst and preparation method thereof 中国科学院山西煤炭化学研究所 2023-12-29 CN claimed
US-20230093480-A1 COMPOSITIONS FOR CLINICAL COMPLICATIONS ASSOCIATED TO DEVICES IMPLANTED IN THE URINARY TRACT Devicare SL (ES) 2023-03-23 US claimed
EP-4084836-A1 COMPOSITIONS FOR CLINICAL COMPLICATIONS ASSOCIATED TO DEVICES IMPLANTED IN THE URINARY TRACT Devicare, S.L. (ES) 2022-11-09 EP claimed
CN-115180605-A Lithium iron phosphate material and preparation method thereof 恒大新能源技术(深圳)有限公司 2022-10-14 CN claimed
CN-115038471-A Compositions for clinical complications associated with devices implanted in the urinary tract 德维护理有限公司 2022-09-09 CN claimed
CN-114624343-A Method for relative quantification of 45 inflammations and immune metabolites in serum 中国科学院大连化学物理研究所 2022-06-14 CN claimed
WO-2021136765-A1 COMPOSITIONS FOR CLINICAL COMPLICATIONS ASSOCIATED TO DEVICES IMPLANTED IN THE URINARY TRACT DEVICARE, S.L. (ES) 2021-07-08 WO claimed
CN-105805426-B Pipeline runs through device 上海火克新材料有限公司 2017-10-27 CN claimed
CN-106508967-A A preparing method of a slow-release composite herbicide 常州市鼎升环保科技有限公司 2017-03-22 CN claimed
CN-106417287-A Herbicide synergy additive 海南博士威农用化学有限公司 2017-02-22 CN claimed
US-20130234071-A1 COMPOSITION OF HUMAN SYNTHETIC URINE DENEAU JOEL DAVID (US) 2013-09-12 US claimed
US-6916426-B2 Method of waste treatment ATD WASTE SYSTEMS INC. (CA) 2005-07-12 US claimed
CN-1258448-A Hand disinfectant for preoperation use and personal hygiene and its preparation TIANJIN AIHUA FRESHENER CO LTD (CN) 2000-07-05 CN claimed
US-4522928-A Removal of metal comtaminants from catalysts using buffered oxalic acid EXXON RESEARCH AND ENGINEERING CO. (US) 1985-06-11 US claimed
US-4007186-A Process for preparing uric acid EMANUEL CARL F 1977-02-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12558363-B2 Compositions for clinical complications associated to devices implanted in the urinary tract FGF23, P2RY10, IPMK GDA 2505/4885ALDH1A1 3056/4885CYP1A2 1897/4885
US-20230093480-A1 COMPOSITIONS FOR CLINICAL COMPLICATIONS ASSOCIATED TO DEVICES IMPLANTED IN THE URINARY TRACT METAP1, MAT2B, IPMK GDA 1539/4885ALDH1A1 3579/4885CYP1A2 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.